XML 62 R46.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Note 4 - Fair Value Measurements (Details Textual) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | 12 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | ---
Mar. 31, 2017 | Jun. 30, 2017 | Jun. 30, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | Aug. 01, 2016 | Mar. 14, 2016 | Nov. 03, 2014
Payment for Contingent Consideration Liability |  | $ 28,500 |  |  |  |  |  |
Payment for Contingent Consideration Liability, Financing Activities |  | 16,700 | $ 21,060 |  |  |  |  |
Payment for Contingent Consideration Liability, Operating Activities |  | 11,800 |  |  |  |  |  |
CyVek, Inc. [Member] |  |  |  |  |  |  |  |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High |  | 35,000 | 35,000 |  |  |  |  |
Business Combination, Liabilities Arising from Contingencies, Amount Recognized |  | 35,000 | 35,000 | $ 35,000 |  |  |  | $ 35,000
Zephyrus [Member] |  |  |  |  |  |  |  |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High |  | 7,000 | 7,000 |  |  |  | $ 7,000 |
Business Combination, Liabilities Arising from Contingencies, Amount Recognized |  |  |  |  |  |  | $ 6,500 |
Payment for Contingent Consideration Liability |  | 3,500 |  |  |  |  |  |
Payment for Contingent Consideration Liability, Financing Activities | $ 3,500 |  |  |  |  |  |  |
Advanced Cell Diagnostics (ACD) [Member] |  |  |  |  |  |  |  |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High |  | 75,000 | 75,000 |  |  | $ 75,000 |  |
Business Combination, Liabilities Arising from Contingencies, Amount Recognized |  |  |  |  |  | $ 37,000 |  |
Payment for Contingent Consideration Liability |  | 25,000 |  |  |  |  |  |
Advance Cell Diagnostics (ACD), Zephyrus, and CyVek Inc.[Member] |  |  |  |  |  |  |  |
Business Combination, Liabilities Arising from Contingencies, Amount Recognized |  | $ 78,500 | $ 78,500 |  |  |  |  |

X
- Definition The total amount of cash outflow for the acquisition of business combination, to settle contingent consideration liability. Includes the operating and financing activities. + References No definition available. + Details
Name: | tech_PaymentForContingentConsiderationLiability
Namespace Prefix: | tech_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 17 -Subparagraph (ee) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3367-108585 + Details
Name: | us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=tech_CyvekIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=tech_ZephyrusMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=tech_AdvancedCellDiagnosticsACDMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=tech_AdvanceCellDiagnosticsACDZephyrusAndCyvekIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |